Safety Starts with Selecting the Targets
Mol Ther
.
2021 Feb 3;29(2):424-425.
doi: 10.1016/j.ymthe.2021.01.011.
Epub 2021 Jan 12.
Author
Fabiana Perna
1
Affiliation
1
Division of Hematology/Oncology, Indiana University School of Medicine, Indianapolis, IN, USA. Electronic address: fabperna@iu.edu.
PMID:
33472030
PMCID:
PMC7854345
DOI:
10.1016/j.ymthe.2021.01.011
No abstract available
Publication types
Review
MeSH terms
Biomarkers, Tumor*
Clinical Decision-Making
Disease Susceptibility
Humans
Neoplasms / etiology*
Neoplasms / therapy
Substances
Biomarkers, Tumor